You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 9,950,125


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,950,125
Title:Needle assisted jet injection administration of testosterone compositions
Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
Inventor(s): Wotton; Paul K. (Newtown, PA), Dave; Kaushik J. (Edison, NJ), Hayes; John W. (Chaska, MN), Sadowski; Peter L. (Woodbury, MN), Jooste; Hermanus L. (Wayne, PA), Jaffe; Jonathan (Annandale, NJ)
Assignee: ANTARES PHARMA, INC. (Ewing, NJ)
Application Number:13/857,859
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,950,125: A Comprehensive Guide

Introduction

When delving into the specifics of a patent, such as United States Patent 9,950,125, it is crucial to understand the broader context of patent analytics, the types of organizations involved, and the specific claims and scope of the patent. This article will provide a detailed analysis of these aspects, drawing from various sources including patent tracking data and analytical tools.

Understanding Patent Analytics

Patent analytics is a critical tool for companies to manage and understand their intellectual property. It involves tracking patents by claims and scope concepts to identify gaps or opportunities in patent coverage[3].

Claim Coverage Matrix

A Claim Coverage Matrix helps in categorizing patents not only by claims but also by overarching scope concepts. This method is particularly useful for filtering, searching, and analyzing large numbers of patent claims concurrently. Tools like ClaimScape® software generate interactive claim charts that can be reviewed by technical experts to determine the applicability of a particular scope concept to a target product or method[3].

Types of Organizations Involved in Patent Awards

Patent awards can be received by various types of organizations, including national laboratories, universities, and private companies.

National Laboratories

National laboratories, such as those involved in the Hydrogen Fuel and Technology Office (HFTO) funding, often lead in research and development (R&D) related to hydrogen storage. They have received a significant portion of patent awards, with 35.7% of all patents awarded to national laboratories[4].

Universities

Universities are primarily involved in R&D activities related to fuel cells and hydrogen production. They account for 18.6% of the overall patent awards[4].

Private Companies

Private companies are the leading recipients of patent awards in the areas of fuel cells and hydrogen production and delivery, accounting for 45.7% of the total patents awarded[4].

Patent Tracking and Analysis

The HFTO-funded project led by Pacific Northwest National Laboratory (PNNL) provides a comprehensive tracking and analysis of U.S. patent applications and awards related to hydrogen and fuel cell technologies.

Cumulative Number of Patents

From 2001 to 2021, there were 1,193 U.S. patent applications resulting from HFTO-funded R&D, with 628 related to fuel cells, 388 to hydrogen production and delivery, and 177 to hydrogen storage. A significant 78% of these patent applications received patent awards, with an average patent lag time of 37 months[1][4].

Specific Analysis of United States Patent 9,950,125

Patent Details

To analyze the scope and claims of a specific patent like United States Patent 9,950,125, one would typically start by examining the patent document itself. Here are some key points to consider:

Invention Overview

  • Title and Abstract: The title and abstract provide a high-level overview of the invention, including its purpose and key features.
  • Background of the Invention: This section explains the context and prior art related to the invention.

Claims

  • Independent and Dependent Claims: Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations.
  • Claim Language: The language used in the claims is critical. It must be precise and clear to define the invention without ambiguity.

Description of the Drawings

  • Figures and Diagrams: These visual aids help in understanding the invention's components and how they interact.

Detailed Description of the Invention

  • Components and Operations: This section provides a detailed explanation of how the invention works, including any specific processes or methods involved.

Scope of the Patent

The scope of a patent is determined by its claims. Here are some key aspects to consider:

Claim Scope Concepts

  • Using tools like ClaimScape®, one can categorize the claims by overarching scope concepts. This helps in understanding how the patent protects the intellectual property and where gaps or opportunities might exist[3].

Claim Coverage Matrix

  • A Claim Coverage Matrix can be used to identify which patents and claims are actively protecting the technology and where there might be gaps in coverage[3].

Examples from Similar Patents

For patents related to hydrogen and fuel cell technologies, the HFTO-funded R&D has resulted in a significant number of patents. For example:

  • Fuel Cell Patents: These patents often involve specific technologies related to fuel cell design, operation, and efficiency. The claims would typically cover the unique aspects of the fuel cell system, such as materials, configurations, and operational methods[1][4].

  • Hydrogen Production and Delivery Patents: These patents focus on methods and systems for producing and delivering hydrogen. The claims would cover the processes, equipment, and safety measures involved in these activities[1][4].

Key Takeaways

  • Patent Analytics: Understanding the claims and scope of a patent is crucial for managing intellectual property effectively.
  • Types of Organizations: National laboratories, universities, and private companies play significant roles in R&D and patent awards.
  • Patent Tracking: Comprehensive tracking and analysis of patent applications and awards help in identifying trends and opportunities.
  • Claim Language: The precision and clarity of claim language are vital for defining the invention and its scope.
  • Scope Concepts: Categorizing claims by scope concepts helps in identifying gaps and opportunities in patent coverage.

FAQs

What is the purpose of a Claim Coverage Matrix in patent analytics?

A Claim Coverage Matrix helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. It categorizes patents by claims and overarching scope concepts[3].

How do national laboratories contribute to patent awards in hydrogen and fuel cell technologies?

National laboratories lead in hydrogen storage R&D and have received a significant portion (35.7%) of the overall patent awards related to HFTO-funded R&D[4].

What is the average patent lag time for HFTO-funded R&D-related patent applications?

The average patent lag time, or the time elapsed between filing and receiving a patent award, is 37 months for HFTO-funded R&D-related patent applications[1][4].

How can tools like ClaimScape® software aid in patent analysis?

ClaimScape® software generates interactive claim charts that can be reviewed by technical experts to determine the applicability of a particular scope concept to a target product or method. This helps in identifying gaps in current coverage and highlighting future design opportunities[3].

What is the significance of claim language in defining the scope of a patent?

The language used in the claims must be precise and clear to define the invention without ambiguity. This ensures that the patent effectively protects the intellectual property[3].

Sources

  1. Department of Energy, "hfto-2021-patent-analysis.pdf" - Department of Energy.
  2. USPTO, "Patent Claims Research Dataset" - USPTO.
  3. Schwegman, "Patent Analytics | Intellectual Property Law" - Schwegman.
  4. Hydrogen and Fuel Cell Technologies Office, "Patent and Technology Portfolios Resulting from HFTO R&D Funding" - Hydrogen and Fuel Cell Technologies Office.
  5. Mintz, "Understanding the 2024 USPTO Guidance Update on AI Patent" - Mintz.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,950,125

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-001 Sep 28, 2018 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY ⤷  Subscribe
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY ⤷  Subscribe
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.